Status:
COMPLETED
Medication Reconciliation in Oncologic Patients
Lead Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Conditions:
Medication Reconciliation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To improve medication reconciliation in oncologic patients in healthcare transitions through an alliance between a Cancer Institute and the community pharmacies and a new integrated IT platform.
Detailed Description
This trial will explore the alliance between a Cancer Institute and the community pharmacies to improve medication reconciliation in healthcare transitions, and will validate a new integrated IT platf...
Eligibility Criteria
Inclusion
- Adult ≥18 years old
- Eastern Cooperative Oncology Group (ECOG) performance status ≤1
- Patients receiving an anticancer treatment
- Clear understanding of the Italian language; written informed consent.
Exclusion
- \- None
Key Trial Info
Start Date :
June 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04796142
Start Date
June 12 2019
End Date
September 15 2023
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alessandro Passardi
Meldola, FC, Italy, 47014